The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

SMO outlines Japan's advantages as a potential clinical trial site, in terms of services and regulatory landscape.

Europe conference, which took place between 29 and 30 April in Barcelona, Spain, industry experts delivered comprehensive ...

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Regulator-approved AI models used in eye care vary widely in providing evidence for clinical performance and lack ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

EuroHeartPath aims to transform cardiovascular care across Europe by analysing how care is organised and identifying best practices. The project ...